Ann: NYR Completes Safety Studies Ahead of Phase I Clinical Trial, page-8

Excellent news. The previous GLP update did indicate an "in vitro" test to be done, but this is not reported on today and the safety study has been concluded irrespective, so maybe it was considered not necessary in the end. ? Anyway we move quickly to Phase 1 now. Whilst the announcement indicard the Phase 1 would continue into CY 2025, what is not going to realized by some is that the testing of patients only takes a week. So its possible (likely) that from the get go we could start to get feedback on the trialling, instead of waiting for months to conclude. Sure, we have to run the trialling for the full period but Mr Market will react well before that if we start getting positive feedback on how things are progressing. Even just a hint will do the trick. Mentime the Walter Reed study is progressing and I expect we dont have too much time to wait before we get some feedback on that, unless WR insist on completing the study first. Either way, I imagine NYR and WR are in regular contact on the trial progress. A positive outcome from WR will see US Dept of Defense kicking in a significant grant given the DoD has stated that secondary brain injury is their biggest medical issue and a so far unmet need for a clinical solution. Once DoD kicks in you can bet the house big pharma will want a seat at the table